Filing Flows › Cannapharmarx (CPMD) › Q1 2026
Cannapharmarx (CPMD) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 20, 2026
Cannapharmarx (CPMD) reported revenue of $627K for the first quarter 2026 (Q1 2026), +87% from a year earlier and +353% from the quarter before. Operating margin was -108.7%, net loss $382K (60.9% of revenue).
Cannapharmarx, Q1 2026: revenue $627K (+87% year over year), operating margin -108.7%, net loss $382K, operating cash flow −$244K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $627K | +353% | +87% |
| Operating profit | −$682K | — | — |
| Net earnings | −$382K | — | — |
| Operating cash flow | −$244K | -123% | — |
What changed
Revenue was $627K in Q1 2026, up 87% year over year and up 353% from the previous quarter.
Operating costs exceeded revenue by $682K, an operating margin of -108.7%. Total costs grew 29% against revenue growth of 87%. The fastest-growing cost line was Other operating costs (+74%). The quarter ended with a net loss of $382K, narrower than the previous quarter's $7.5M loss. Non-operating items added $300K, -79% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$244K. Non-cash charges added back $16K of depreciation and amortization. Working capital and other items added $123K.
Questions
What was Cannapharmarx's revenue in the first quarter 2026?
Cannapharmarx (CPMD) reported revenue of $627K for the first quarter 2026 (Q1 2026), +87% from a year earlier and +353% from the quarter before.
Was Cannapharmarx profitable in the first quarter 2026?
Operating loss was $682K (-108.7% of revenue) and net loss $382K.
Source: Cannapharmarx 10-Q on SEC EDGAR.